LIQUIDIA CORPORATION Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- LIQUIDIA CORPORATION stock issued during period, value, new issues for the quarter ending 2024-09-30 was $63.68M.
- LIQUIDIA CORPORATION stock issued during period, value, new issues for the quarter ending 2024-03-31 was $74.87M.
- LIQUIDIA CORPORATION stock issued during period, value, new issues for the quarter ending 2022-06-30 was $54.46M, a 150.85% increase year-over-year.
- LIQUIDIA CORPORATION stock issued during period, value, new issues for the quarter ending 2021-06-30 was $21.71M.
- LIQUIDIA CORPORATION stock issued during period, value, new issues for fiscal 2024 was $138.55M, a 474.76% increase from fiscal 2023.
- LIQUIDIA CORPORATION stock issued during period, value, new issues for fiscal 2023 was $24.11M, a 55.74% decline from fiscal 2022.
- LIQUIDIA CORPORATION stock issued during period, value, new issues for fiscal 2022 was $54.46M, a 150.86% increase from fiscal 2021.
- LIQUIDIA CORPORATION stock issued during period, value, new issues for fiscal 2021 was $21.71M, a 69.43% decline from fiscal 2020.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2024-12-31 | $138.55M 10-K · filed 2026-03-05 | |
| 2024-09-30 | $63.68M 10-Q · filed 2025-11-03 | |
| 2024-03-31 | $74.87M 10-Q · filed 2025-11-03 | |
| 2023-12-31 | $24.11M 10-K · filed 2026-03-05 | |
| 2022-12-31 | $54.46M 10-K · filed 2024-03-13 | |
| 2022-06-30 | $54.46M 10-Q · filed 2023-11-07 | |
| 2021-12-31 | $21.71M 10-K · filed 2023-03-20 | |
| 2021-06-30 | $21.71M 10-Q · filed 2022-11-08 | |
| 2020-12-31 | $71.02M 10-K · filed 2022-03-17 | |
| 2020-09-30 | $70.29M 10-Q · filed 2021-11-03 | |
| 2020-03-31 | $725.40K 10-Q · filed 2021-11-03 | |
| 2019-12-31 | $60.93M 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |